Kenneth Candido, MD
Interventional Pain Medicine · Chicago, ILNPI 1518937937
Payments from drug & device makers
Across 294 payments — averaging $1731.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$232K
- Seikagaku Corporation$176K
- Abbott$69K
- Pfizer$21K
- Ferring Pharmaceuticals Inc.$4K
- Lilly USA, LLC$4K
- plus $4K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 10 | $232,295 |
| Seikagaku Corporation | 16 | $176,026 |
| Abbott | 157 | $69,079 |
| Pfizer | 1 | $20,614 |
| Ferring Pharmaceuticals Inc. | 11 | $3,674 |
| Lilly USA, LLC | 1 | $3,600 |
| Boston Scientific | 14 | $644 |
| Biotronik NRO, Inc. | 8 | $520 |
| Avanos Medical | 6 | $472 |
| Si-bone, Inc. | 9 | $271 |
| Curonix LLC | 4 | $256 |
| Medtronic(2 entities) | 13 | $256 |
| SPR Therapeutics, Inc | 5 | $223 |
| Amgen | 15 | $223 |
| Stimwave Technologies Incorporated | 2 | $193 |
| Saluda Medical Americas, Inc. | 1 | $119 |
| Zavation Medical Products, LLC | 1 | $94 |
| Nevro Corp. | 3 | $90 |
| Collegium Pharmaceutical, Inc. | 3 | $87 |
| GRT US Holding, Inc. | 1 | $56 |
| Nalu Medical, Inc. | 1 | $49 |
| Mindray DS USA, Inc. | 1 | $33 |
| Vertiflex, Inc. | 2 | $30 |
| Globus Medical | 1 | $25 |
| Merz Pharmaceuticals, LLC | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Valinor Pharma, LLC | 1 | $20 |
| Tolmar, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| USWM, LLC | 1 | $16 |
| Lenoss Medical Inc | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$509,066 in reported general payments places this provider in the 95th percentile of 93 interventional pain medicine providers in Illinois.
See all interventional pain medicine providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional pain medicine in Chicago
- Timothy LubenowChicago$856K
- Sandeep AminChicago$430K
- Asokumar BuvanendranChicago$182K
- Matthew JaycoxChicago$129K
- Hong VoChicago$91K
- Adam YoungChicago$29K
- Salman SagarwalaChicago$26K
- Sameer ShahChicago$10K
- James DiesfeldChicago$10K
- Xiaoyuam XieChicago$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.